Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
The PGD2/DP2 axis promotes pro-inflammatory responses but attenuates an antigen-presenting role of human basophils.
Journal: Communications biology
Published: September 23, 2025
Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial.
Journal: The Lancet. Respiratory medicine
Published: November 23, 2022
Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series.
Journal: American journal of reproductive immunology (New York, N.Y. : 1989)
Published: December 04, 2021
Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor.
Journal: Respiratory research
Published: May 31, 2021
Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019.
Journal: Infectious diseases and therapy
Published: February 02, 2021
The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D2 Production Are Attenuated by PGD2 Receptor 2 Antagonism.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 02, 2020
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Journal: Trials
Published: June 19, 2020
Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251).
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: May 21, 2020
KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma.
Journal: The New England journal of medicine
Published: May 18, 2017
Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
Journal: JAMA
Published: October 28, 2015
Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.
Journal: American journal of respiratory and critical care medicine
Published: January 07, 2015
Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma.
Journal: American journal of respiratory and critical care medicine
Published: August 28, 2014
Last Updated: 09/26/2026